(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EVERIS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

EVERIS

ST13

US500000079170977

Class

1

Filing

79170977

Registration

4975511

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

10/08/2025

Trademark type

Word

Nice classes

1

Filing date

07/08/2015

Registration date

06/14/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/07/2025

Last transaction

10/08/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Bagsvaerd, DK

Examiner

SCHIMPF,TIMOTHY O

Current location

Historical data usage

Holders and representatives

Holders

Novozymes A/S
Novozymes A/S

Representatives

Vincent O. Wagner Woodard, Emhardt, Henry, Reeves & Wagner LLP

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Enzymes as ingredients in products for use in cleaning of medical devices

Publications

History of USPTO decisions and trademark events.

40 publications found

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

10/07/2025

71AG

REGISTERED-SEC.71 ACCEPTED

10/07/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/06/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

07/03/2025

ES71

TEAS SECTION 71 RECEIVED

06/30/2025

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

06/14/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/20/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/14/2025

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

06/10/2023

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

06/10/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/29/2023

ES75

TEAS SECTION 71 & 15 RECEIVED

11/15/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/14/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/14/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/24/2019

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

10/02/2016

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/15/2016

FIMP

FINAL DISPOSITION PROCESSED

09/14/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/14/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

06/14/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/29/2016

PUBO

PUBLISHED FOR OPPOSITION

03/29/2016

GPNX

NOTIFICATION PROCESSED BY IB

03/25/2016

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/09/2016

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/09/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/09/2016

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/26/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/17/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/16/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/15/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/15/2016

RFNT

REFUSAL PROCESSED BY IB

11/17/2015

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/23/2015

RFRR

REFUSAL PROCESSED BY MPU

10/23/2015

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/22/2015

CNRT

NON-FINAL ACTION WRITTEN

10/21/2015

DOCK

ASSIGNED TO EXAMINER

10/19/2015

MAFR

APPLICATION FILING RECEIPT MAILED

08/25/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/21/2015

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/20/2015

Continuous trademark protection

Get notified about every new filing that threatens EVERIS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.